{"id":"W2020779524","doi":"10.1358/dot.2004.40.10.863742","title":"Gefitinib: Current status in the treatment of non-small cell lungcancer","year":2004,"lang":"en","type":"review","venue":"Drugs of today","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Gefitinib; Medicine; Lung cancer; Tolerability; Oncology; Epidermal growth factor receptor; Internal medicine; Chemotherapy; Tyrosine-kinase inhibitor; Cancer; Adverse effect","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000857562,0.0003341268,0.001388689,0.0001840847,0.00002372017,0.000006490142,0.0001372685,0.0001098254,0.00007013006],"category_scores_gemma":[0.000006477615,0.0001797232,0.000546474,0.0002728607,0.00005949388,0.00002093292,0.0000140242,0.0001445696,0.00001724284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007666033,"about_ca_system_score_gemma":0.001451057,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001085032,"about_ca_topic_score_gemma":0.00006344928,"domain_scores_codex":[0.9984857,0.00005541494,0.0006478372,0.0002828302,0.0002502808,0.000277979],"domain_scores_gemma":[0.9987848,0.0001447629,0.0004278536,0.0004970867,0.00006901331,0.00007642859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001532276,0.001909788,0.0001437374,0.01809927,0.0002674476,0.00001509527,0.004389139,0.000005347261,3.98505e-7,0.0000494127,0.0002075746,0.9748974],"study_design_scores_gemma":[0.002297254,0.0006046097,0.0002494515,0.01465147,0.003314219,0.000004445058,0.0002145822,6.500628e-7,0.00002644151,0.00001584848,0.9784815,0.0001395148],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006766252,0.9906311,0.000003994742,0.00004864819,0.0002841002,0.002111855,0.0003762784,0.000008394004,0.005858974],"genre_scores_gemma":[0.001080031,0.9971522,0.0002037882,0.00001573856,0.0001156579,0.0004672395,0.000394207,0.00003657075,0.0005345742],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9782739,"threshold_uncertainty_score":0.7328901,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03334470967723603,"score_gpt":0.3830884928690895,"score_spread":0.3497437831918535,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}